Skip to main content

Table 3 Clinical characteristics of patients

From: A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes

Number

16

Mean Age

51.8 (35–75 years)

Histology

 

Squamous

16 (100%)

FIGO Stage*

 

IIB

8 (50%)

IIIB

8 (50%)

Performance Status**

 

0

10 (62%)

1

6 (38%)

  1. *International Federation of Gynecology and Obstetrics,
  2. ** World Health Organization Criteria